E-Scopics

#EScopicsAdventCalendar🎄🎅 Day 19 "It was wonderful to see my transplanted liver!" Today, in our Advent Calendar, we are happy to share the testimony of Carol Roberts, who received a liver transplant and recently volunteered to get a demonstration with #Hepatoscope. Here is Carol’s story and experience with Hepatoscope. “In 1999, I was referred to a GI doctor because of discolored eyes and a confirmatory liver panel lab test. I was diagnosed with #PBC and already had cirrhosis. #URSO treatment lowered my labs to just above normal and improved the unbearable #itching. I felt better than I had felt in 10 years, until mid 2020 when my labs started to increase slightly and ascites started to develop. In 2021, as diuretics could not reduce ascites and paracentesis was required, I was told I needed to undergo #livertransplantation. At the age of 69 and after 20+ years with PBC, I thought I could keep my liver for my entire life, and I knew how many younger people suffered and needed a liver. At the urging of my family, and realizing how devastated my grandsons would be to lose their grandma, I had agreed to be evaluated. Because of my blood type and my kidneys were now involved, I was placed at the top of the #transplantlist in my area. My transplant happened 5 days after listing, in May 2021. During my PBC patient journey, I had experienced several exams prior to my transplant from my local hospital. The short demo I had on me with Hepatoscope was the first ever ultrasound imaging of my transplanted liver. The demo was quicker and the vibration was less intense than any of my previous exams. The imaging was also so clear compared to other imaging devices. Of course it was wonderful to see my transplanted liver. I really encourage liver specialists and GPs to do a comparison of all technology available so the equipment they use for their patients gives them the best imaging available and the required quantitative capabilities to assist them in treating their patients. It was really wonderful to “meet” visually with my transplanted liver! Fatty Liver Alliance Fatty Liver Foundation Global Liver Institute European Liver Patients' Association - ELPA

#EScopicsAdventCalendar🎄🎅 Day 18 ✨ E-Scopics will attend the EASL | The Home of Hepatology #SLDSummit 2025, in Estoril, Portugal. ✨ Join our poster presentation (PO1-10) on Friday, 24 Jan, 10:30 to understand how #BMode imaging and #stiffness #imaging improves transient elastography, regardless of operator experience. 🚀 Stay tuned and connect with our Clinical Science Manager Cindy Serdjebi for more information on #Hepatoscope.

#EScopicsAdventCalendar🎄🎅 Day 17 🚀 #2024 has been a tremendous year for the #MASLD / #MASH community. Here are this year's key milestones we wanted to highlight: - March: #resmetiron (Rezdiffra, Madrigal Pharmaceuticals), was conditionally approved by the @US FDA, becoming the first ever anti-MASH drug therapy. - #Rezdiffra labeling does not require liver #biopsy for treatment, addressing the concerns of many healthcare professionals, and hearing patients' voices. - June: E-Scopics launched the commercialization of #Hepatoscope in Europe at #EASL2024. - EASL | The Home of Hepatology, European Association for the Study of Obesity (EASO) and European Association for the Study of Diabetes e.V. (EASD) co-published new clinical practice guidelines on the management of #MASLD, aligning with the American Association for the Study of Liver Diseases (AASLD) recommendations. Assessment of the risk for advanced #fibrosis and liver-related outcomes in people with metabolic risk factors or steatotic liver diseases is recommended based on the use of FIB-4 score and on liver stiffness measurements. This has paved a way for earlier detection of at-risk patients in hepatology centers, but also in endocrinology and diabetology units. - September: #NIMBLE 1.1 project (Foundation for the National Institutes of Health's Post) published long-anticipated data on the reproducibility and repeatability of ultrasound shear wave and transient elastography assessed in MASLD patients. Variability of each investigated system could be defined: serial examination variability is lower when performed with the same system. - November: Topline results of the #ESSENCE Phase 3 trial investigating #semaglutide from @novonordisk were presented at the American Association for the Study of Liver Diseases (AASLD) #TLM2024: semaglutide slowed MASH progression and reversed existing liver damage. This news brings tremendous hope for patients as semaglutide is already available in many countries around the world outside of NASH treatment indication/in other therapeutic indications. Rebecca Taub, Global Liver Institute, PBC Foundation, Michelle Long, CYRIELLE CAUSSY, Hospices Civils de Lyon - HCL, Claude Sirlin, Tania Kamphaus, Anthony Samir

#EScopicsAdventCalendar🎄🎅 Day 16 🚀 Last friday, we released a post on our first publication in a peer-reviewed scientific journal, focusing on the measurement of fat-related #ultrasound parameters with #Hepatoscope! Here is the second manuscript that was published this year! 🎯 Key takeaway? Larger ROIs and multiple measurements improve reliability, making QUS exams faster and more dependable for clinicians. ✨ Hepatoscope® is an ultraportable, cost-effective, and user-friendly ultrasound system designed to asses and monitor liver fat reliably precision.✨ Here's why it matters: ✅ Innovative Technology: Measures ultrasound attenuation, backscattering coefficient, and speed of sound in a large region of interest (ROI), enhancing accuracy and reliability. ✅ Clinical Impact: Demonstrates excellent reproducibility, even across operators, while aligning well with established diagnostics l ✅ Overall: With metabolic liver diseases like #MASLD and #MASH on the rise, #Hepatoscope® could play a key role in liver assesment and monitoring, making liver care more accessible and efficient. Check out the study for more details! #InnovationInHealthcare #LiverHealth #Ultrasound #QUS #SteatosisAssessment

#EScopicsAdventCalendar 🎄🎅Day 13 Earlier this year, we were excited to share our first publications in peer-reviewed scientific journals, focusing on the measurement of fat-related #ultrasound parameters with #Hepatoscope! Here is a catch-up session with the first manuscript. Key takeaways are: ✅ The study demonstrates the feasibility and accuracy of implementing QUS (#quantitative ultrasound) on Hepatoscope, a new #ultraportable #pointofcare device. ✅ Hepatoscope offers a portable and accessible alternative to traditional methods for liver fat assessment. ✅ The results demonstrate good reliability of QUS measurements and promising correlation with another ultrasound-based #noninvasive test for steatosis. This research paves the way for: 💊 Large-scale programs to identify individuals at risk for steatotic liver disease 👨⚕️ Improved monitoring of treatment efficacy for patients with #MASLD #MASH 🏥 Enhanced point-of-care noninvasive tests in various clinical settings Read more here: https://lnkd.in/dcXdkhqG Baptiste HERIARD DUBREUIL Adrien Besson Claude COHEN-BACRIE Joel Gay Jonathan Mamou CHU de Bordeaux ULTRASOUND IN MEDICINE AND BIOLOGY #MASLD #MASH #hepatology #liverhealth, #DIACEPA

#EScopicsAdventCalendar🎄🎅 Day 11 ✨ Why choose #Hepatoscope, the last-generation transient elastography #ultrasound system? ✨ 🚀 It provides quantitative measurements for #liver stiffness and ultrasound parameters 🏥 It is #ultraportable, so you can bring it at #pointofcare 2️⃣ The examination is quick: only takes 2 minutes. 👩⚕️ #image guidance makes it easy to use, by any #healthcare professionals #Hepatoscope truly revolutionizes non-invasive tests as an aid for liver health assessment! #fibrosis, #steatosis, #patient #management

#EScopicsAdventCalendar🎄🎅 Day 10 ✨ The essentials of a liver exam with #Hepatoscope ✨ 🚀 #Hepatoscope is a non-invasive, bedside ultraportable ultrasound system. It allows healthcare professionals to easily locate the liver and perform key measurements to assess liver health, under image guidance. ✨ Want to see how the exam works? Check out #Hepatoscope demonstration on YouTube : https://lnkd.in/eRjyK7UZ #LiverHealth #LiverAwareness #Hepatoscope #HealthcareInnovation #EScopics Fatty Liver Alliance Global Liver Institute PBC Foundation Liver Education Advocates (formerly NASH kNOWledge) European Liver Patients' Association - ELPA Fatty Liver Foundation

#EScopicsAdventCalendar🎄🎅 Day 9 🤔 What is the regulatory status of #Hepatoscope? #Hepatoscope is an ultraportable ultrasound imaging system used to perform non-invasive #liver assessment. More precisely, it is indicated for imaging of anatomical structures in the abdomen and measurement of physical properties (stiffness and quantitative #ultrasound) in the liver and the spleen. The parameters provided by Hepatoscope have been shown to be related to liver #fibrosis and #steatosis and may be used as an aid to the #diagnosis, #monitoring and clinical management of both adult and #pediatric populations. ✨ #Hepatoscope is US FDA-cleared and CE-marked ! ✨ Please contact us at sales-usa@e-scopics.com / sales-europe@e-scopics.com for more information.

#EScopicsAdventCalendar🎄🎅 Day 6 ✨ What is #Hepatoscope? ✨ #Hepatoscope = 1 probe + 1 software. 🚀 It is an #ultraportable #ultrasound system providing: - B-Mode #image guidance to target the #liver - Transient #elastography using a self-vibrating probe for liver stiffness measurement (LSM) - All premium #ultrasound fat-related parameters (attenuation, backscattering coefficient and speed of sound) - A safe, reliable and quick non-invasive liver assessment tool Thanks to its reduced size, #Hepatoscope can be implemented and deployed anywhere at #pointofcare, enabling its use in #hepatology and dedicated #research centers, but also in #diabetology, #gastroenterology clinics or in primary and community-care settings for large-scale programs. #fibrosis #steatosis #ultrasound

#EScopicsAdventCalendar🎄🎅 Day 5 ✨ What is #ultrasound -based #elastography? ✨ In hepatology, #liver stiffness can be measured, as part of liver #health assessment, using two types of ultrasound-based elastography. 1️⃣ Historically, transient elastography (or TE) was the first modality. It uses a self-vibrating probe to generate a mechanical vibration (50 Hz) that induces shear waves in the liver. The shear wave is tracked along one single line. 2️⃣ Shear wave elastography (#SWE) was the second generation of ultrasound elastography and uses acoustic radiation force (100-300 Hz) to generate shear waves in tissue. The shear wave propagation is then tracked in 2D to compute a stiffness map in real-time thanks to #ultrafast #imaging. SWE can also be performed under image guidance (B-Mode) during the procedure, allowing to "see" the liver. As a result of #innovative #research, E-Scopics has developed #Hepatoscope, which combines the best of both worlds, using the mechanical vibration from transient elastography and ultrafast imaging capabilities in 2D under image guidance. Transient elastography has become the most widely used modality and has benefited from years of clinical evidence with well-established diagnostic cut-off values. However, these cut-offs are not applicable to SWE. Therefore, #Hepatoscope is a novel medical device that can benefit from the large amount of data available for transient elastography. Fatty Liver Alliance, Liver Education Advocates (formerly NASH kNOWledge), Global Liver Institute, Institut Langevin - Ondes et images, ESPCI Paris - PSL, LabTAU, Inserm U1032, #NIMBLE, #LITMUS, Virginia Commonwealth University, Harvard University ,ITECH Lyon #QIBA.